Integer Holdings (ITGR) Liabilities from Discontinued Operations (2017 - 2024)

Integer Holdings (ITGR) posted Liabilities from Discontinued Operations of 4969000.0 for Q3 2024, up 101.66% sequentially from 2464000.0 in Q4 2023.

Integer Holdings (ITGR) Liabilities from Discontinued Operations (2017 - 2024) Analysis & Trends

Integer Holdings has reported Liabilities from Discontinued Operations for 4 years, with the latest figure at 4969000.0 in Q3 2024.

Quarterly Liabilities from Discontinued Operations changed N/A year-over-year to 4969000.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was 4969000.0 (changed N/A YoY) and the FY2023 annual result came in at 2464000.0, changed N/A from the prior year.
Liabilities from Discontinued Operations grew to 4969000.0 in Q3 2024 per ITGR's latest filing, from 2464000.0 in the prior quarter.
Over five years, Liabilities from Discontinued Operations peaked at 4969000.0 in Q3 2024 and troughed at 2464000.0 in Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn
10	Integer Holdings	4.26 Bn	4.24 Bn	112.94 Mn

Download Data